MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
Clinical trial NCT07607769 · RECRUITING
Trial details
- NCT number
- NCT07607769
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-16
- Primary completion
- 2028-10-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.